The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: Serotonin, norepinephrine and dopamine reuptake inhibitor

@article{Jin2012TheEO,
  title={The extracts of Fructus Akebiae, a preparation containing 90\% of the active ingredient hederagenin: Serotonin, norepinephrine and dopamine reuptake inhibitor},
  author={Zeng Jin and Nana Gao and Dan Zhou and M G Chi and Xue-Mei Yang and Jiang-Ping Xu},
  journal={Pharmacology Biochemistry and Behavior},
  year={2012},
  volume={100},
  pages={431-439}
}

Figures and Tables from this paper

The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity
  • Zeng Jin, Nana Gao, Yu Tang
  • Biology, Psychology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2014
Receptor and transporter binding and activity profiles of albiflorin extracted from Radix paeoniae Alba
TLDR
Albiflorin is a novel 5-HT and NE reuptake inhibitor with high selectivity, and characterised the in vivo effect of alb iflorin on monoaminergic systems by using microanalysis.
Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review
TLDR
The extensive anti-tumor activity indicates that HG has the potential to be a highly effective chemotherapy agent, and future studies of HG focusing on extending the half-life, improving bioavailability, enhancing pharmacological activity, as well as decreasing or avoiding hemolysis by structural modification or formulation design could potentially accelerate HG from the preclinical to clinical research phase.
Involvement of norepinephrine and serotonin system in antidepressant-like effects of hederagenin in the rat model of unpredictable chronic mild stress-induced depression
TLDR
The findings confirm the antidepressant-like effects of HG in a behavioral despair test and UCMS rat model, which may be associated with monoamine neurotransmitters and 5-HTT mRNA expression.
Clinical effect of the extract of TCM Fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease.
TLDR
It can be seen that the addition of FAE can significantly improve the clinical symptoms and serum biochemical indicators such as ALT, AST, TG and TC in patients with non-alcoholic fatty liver disease, which is supported by some histological evidence.
Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies.
TLDR
The purpose of this narrative review is to provide an update regarding medicinal plants from the year 2000 to the present to examine the therapeutic potential of these antidepressant-like plants in order to contribute to the development of new therapeutic methods to alleviate the tremendous burden that depression causes worldwide.
Potential plant-derived catecholaminergic activity enhancers for neuropharmacological approaches: A review.
Effects of Fructus Akebiae on learning and memory impairment in a scopolamine-induced animal model of dementia
TLDR
The results suggest that FAE is an effective cognitive enhancer, and thus highlights the value of a multi-target strategy to address the complexity of cognitive dysfunction in Alzheimer’s disease.
Preclinical Safety of the Root Extract of Polygala tenuifolia Willdenow in Sprague-Dawley Rats and Beagle Dogs
TLDR
The results showed that the acute or subchronic toxicity of the root extract of Polygala tenuifolia might not be toxic to rats and dogs.
...
1
2
3
...

References

SHOWING 1-10 OF 44 REFERENCES
Antidepressant effect of the extracts from Fructus Akebiae
Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang
Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula.
Behavioral and Biochemical Studies of Dichloromethane Fraction From the Areca catechu Nut
Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.
TLDR
Novel findings, not widely described previously, suggest that many of the individual drugs studied in these experiments possess some structural characteristic that determines affinity for several G protein-coupled, but not muscarinic, receptors.
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake
TLDR
LY248686 has a favorable pharmacological profile as a potential antidepressant drug because of its lack of affinity for receptors of 5-HT, NE, DA, acetylcholine, histamine and naloxone, and its ability to inhibit 5- HT and NE uptake simultaneously.
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
TLDR
In conclusion, S33005 interacts potently with SERTs and, less markedly, with NETs and enhances extracellular levels of 5-HT and NE throughout corticolimbic structures and selectively elevates dialysis levels of DA in frontal cortex versus subcortical regions.
...
1
2
3
4
5
...